TrialX
Image

InO - A Retrospective Study of UK Patients With Leukaemia

InO - A Retrospective Study of UK Patients With Leukaemia

Recruiting
18 years and older
All
Phase N/A

Overview

The purpose of this study is to describe the demographics and clinical characteristics, treatment pathway, and effectiveness and safety of inotuzumab ozogamicin in patients with relapsed/refractory B-cell acute lymphoblastic leukaemia treated with inotuzumab ozogamicin in the real-world.

Eligibility

Inclusion Criteria:

  • Patients with relapsed/refractory ALL.
  • Patients who initiated InO between 1st of June 2016 and date of data collection.
  • Patients who accessed InO treatment via NHS commissioning, via the CUP, or via private purchase.
  • Patient aged 18 years old at initiation of InO treatment

Exclusion Criteria:

  • Patients initiated on treatment with InO at a different hospital than the ones selected in this study.
  • Patients with <3 months of follow-up since index date, unless death occurs <3 months from index date.

Study details
    childhood ALL

NCT04456959

Pfizer

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.